Stephen Hall
Impact in
- Rheumatology top 0.05%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Dupuytren's Contracture and Treatments
- Immunology top 2%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Rheumatology 71
- Rheumatoid Arthritis Research and Therapies 43
- Spondyloarthritis Studies and Treatments 21
- Osteoarthritis Treatment and Mechanisms 4
-
- Minerals Flotation and Separation Techniques 3
- Coagulation and Flocculation Studies 2
- Co-authors
- Rachelle Buchbinder (13 shared papers)Roy Fleischmann (10 shared papers)Mark C. Genovese (11 shared papers)Patrick Durez (10 shared papers)Philip J. Mease (11 shared papers)Z. John Zhong (1 shared paper)Sandra Navarra (1 shared paper)Roger A. Levy (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (15 papers)The Lancet (8 papers)Lara D. Veeken (6 papers)The Journal of Rheumatology (5 papers)RMD Open (4 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Stephen Hall
111 papers receiving 10k citations
Stephen Hall's Hit Papers
Peers
Comparison fields: 5 of 142
- Rheumatology 7.1k
- Immunology 847
- Pulmonary and Respiratory Medicine 641
- Orthopedics and Sports Medicine 137
- Oncology 296
Countries citing papers authored by Stephen Hall
This map shows the geographic impact of Stephen Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Hall more than expected).
Fields of papers citing papers by Stephen Hall
This network shows the impact of papers produced by Stephen Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Hall. The network helps show where Stephen Hall may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2011 | 1631 |
| 2 | Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial Hit paper breakdown → | 2008 | 701 |
| 3 | Tofacitinib versus Methotrexate in Rheumatoid Arthritis Hit paper breakdown → | 2014 | 659 |
| 4 | Takayasu arteritis. A study of 32 North American patients. Hit paper breakdown → | 1985 | 505 |
| 5 | Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study Hit paper breakdown → | 2008 | 467 |
| 6 | Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis Hit paper breakdown → | 2017 | 463 |
| 7 | Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial Hit paper breakdown → | 2017 | 415 |
| 8 | Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis Hit paper breakdown → | 2013 | 399 |
| 9 | Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor Hit paper breakdown → | 2014 | 375 |
| 10 | Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial Hit paper breakdown → | 2018 | 372 |
| 11 | Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial Hit paper breakdown → | 2017 | 340 |
| 12 | 2013 | 302 | |
| 13 | 2010 | 264 | |
| 14 | 2008 | 254 | |
| 15 | 2013 | 220 | |
| 16 | A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis. | 2004 | 168 |
| 17 | 2008 | 163 | |
| 18 | 2016 | 159 | |
| 19 | 2002 | 141 | |
| 20 | 2020 | 130 |
About Stephen Hall
Stephen Hall is a scholar working on Rheumatology, Water Science and Technology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 112 papers that have together received 10.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (43 papers), Spondyloarthritis Studies and Treatments (21 papers), Vasculitis and related conditions (7 papers), Osteoarthritis Treatment and Mechanisms (4 papers), Mineral Processing and Grinding (3 papers), Minerals Flotation and Separation Techniques (3 papers), Coagulation and Flocculation Studies (2 papers) and Bone health and osteoporosis research (2 papers). The work is most often cited by research in Rheumatology (7.1k citations), Immunology (847 citations), Pulmonary and Respiratory Medicine (641 citations), Orthopedics and Sports Medicine (137 citations) and Oncology (296 citations). Stephen Hall has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Rachelle Buchbinder, Roy Fleischmann, Mark C. Genovese, Patrick Durez, Philip J. Mease, Z. John Zhong, Sandra Navarra, Roger A. Levy, Michelle Petri and Joung‐Liang Lan. Their work appears in journals such as Annals of the Rheumatic Diseases, The Lancet, Lara D. Veeken, The Journal of Rheumatology and RMD Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.